RUNX3 and neoplasm: Consistently, we observed a higher frequency of deletions in CDH1, which encodes E-cadherin, a critical suppressor of tumor metastasis [32], and RUNX3, which promotes E-cadherin expression and inhibits EMT [33], in these patients.